The history of cancer pain and bone-targeted agents: 10 most commonly asked questions

References

• O’TooleGCBolandPMetastatic bone cancer pain: etiology and treatment optionsCurr Pain Headache Rep200610428829216834944
   PubMedGoogle Scholar
• BellREfficacy of ibandronate in metastatic bone disease: review of clinical dataOncologist200510Suppl 181316264107
   PubMed Web of Science ®Google Scholar
• VardyJAgarMNonopioid drugs in the treatment of cancer painJ Clin Oncol201432161677169024799483
   PubMed Web of Science ®Google Scholar
• AaproMAbrahamssonPABodyJJGuidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panelAnn Oncol200819342043217906299
   PubMed Web of Science ®Google Scholar
• PavlakisNStocklerMBisphosphonates for breast cancerCochrane Database Syst Rev20021CD003474
   Google Scholar
• ColemanREBisphosphonates: clinical experienceOncologist20049Suppl 41427
   PubMedGoogle Scholar
• SmallEJSmithMRSeamanJJPetroneSKowalskiMOCombined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancerJ Clin Oncol200321234277428414581438
   PubMed Web of Science ®Google Scholar
• RosenLSGordonDHDuganWZoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesionCancer20041001364314692022
   PubMed Web of Science ®Google Scholar
• RosenLSGordonDTchekmedyianNSLong-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trialCancer2004100122613262115197804
   PubMed Web of Science ®Google Scholar
• KohnoNAogiKMinamiHZoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trialJ Clin Oncol200523153314332115738536
   PubMed Web of Science ®Google Scholar
• VogelCLYanagiharaRHWoodAJSafety and pain palliation of zoledronic acid in patients with breast cancer, prostate cancer, or multiple myeloma who previously received bisphosphonate therapyOncologist20049668769515561812
   PubMed Web of Science ®Google Scholar
• WardleyADavidsonNBarrett-LeePZoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administrationBr J Cancer200592101869187615870721
   PubMed Web of Science ®Google Scholar
• SaadFGleasonDMMurrayRA randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinomaJ Natl Cancer Inst2002941458146812359855
   PubMed Web of Science ®Google Scholar
• RosenLSGordonDTchekmedyianSZoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study GroupJ Clin Oncol200321163150315712915606
   PubMed Web of Science ®Google Scholar
• RosenLSGordonDKaminskiMZoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trialCancer J20017537738711693896
   PubMed Web of Science ®Google Scholar
• GralowJTripathyDManaging metastatic bone pain: the role of bisphosphonatesJ Pain Symptom Manage200733446247217397707
   PubMed Web of Science ®Google Scholar
• HadiSFanGHirdAEKirou-MauroAFilipczakLAChowESymptom clusters in patients with cancer with metastatic bone painJ Palliat Med200811459160018454612
   PubMed Web of Science ®Google Scholar
• HadiSZhangLHirdAde SaEChowEValidation of symptom clusters in patients with metastatic bone painCurr Oncol200815521121819008995
   PubMed Web of Science ®Google Scholar
• CarrDBGoudasLCBalkEMBlochRIoannidisJPLauJEvidence report on the treatment of pain in cancer patientsJ Natl Cancer Inst Monogr2004322331
   Google Scholar
• DavisMPWalshDLagmanRLegrandSBControversies in pharmacotherapy of pain managementLancet Oncol20056969670416129370
   PubMed Web of Science ®Google Scholar
• MitraRJonesSAdjuvant analgesics in cancer pain: a reviewAm J Hosp Palliat Care2012291707921712306
   PubMed Web of Science ®Google Scholar
• LussierDHuskeyAGPortenoyRKAdjuvant analgesics in cancer pain managementOncologist20049557159115477643
   PubMed Web of Science ®Google Scholar
• MercadanteSArcuriEPharmacological management of cancer pain in the elderlyDrugs Aging200724976177617727305
   PubMed Web of Science ®Google Scholar
• MercadanteSFulfaroFManagement of painful bone metastasesCurr Opin Oncol200719430831417545792
   PubMed Web of Science ®Google Scholar
• McdonnellFJSloanJWHamannSRAdvances in cancer pain managementCurr Pain Headache Rep20015326527111309214
   PubMedGoogle Scholar
• OuraSHiraiIYoshimasuTKokawaYSasakiRClinical efficacy of bisphosphonate therapy for bone metastasis from breast cancerBreast Cancer2003101283212525760
   PubMedGoogle Scholar
• MachereySMonsefIJahnFBisphosphonates for advanced prostate cancerCochrane Database Syst Rev20171212CD00625029278410
   PubMedGoogle Scholar
• O’CarriganBWongMHWillsonMLStocklerMRPavlakisNGoodwinABisphosphonates and other bone agents for breast cancerCochrane Database Syst Rev20171010CD00347429082518
   PubMedGoogle Scholar
• Porta-SalesJGarzón-RodríguezCLlorens-TorroméSBrunelliCPigniACaraceniAEvidence on the analgesic role of bisphosphonates and denosumab in the treatment of pain due to bone metastases: a systematic review within the European Association for Palliative Care guidelines projectPalliat Med201731152527006430
   PubMed Web of Science ®Google Scholar
• KongsgaardUKaasaSDaleOPalliative Treatment of Cancer-Related PainOslo, NorwayKnowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH)2005
   Google Scholar
• von MoosRCostaLRipamontiCINiepelDSantiniDImproving quality of life in patients with advanced cancer: targeting metastatic bone painEur J Cancer201771809427984770
   PubMed Web of Science ®Google Scholar
• ChenFPuFSafety of denosumab versus zoledronic acid in patients with bone metastases: a meta-analysis of randomized controlled trialsOncol Res Treat2016397–845345927487236
   PubMed Web of Science ®Google Scholar
• MitraSKhandelwalPRobertsKKumarSVadiveluNPain relief in laparoscopic cholecystectomy: a review of the current optionsPain Pract201212648549622008277
   PubMed Web of Science ®Google Scholar
• LucasLKLipmanAGRecent advances in pharmacotherapy for cancer pain managementCancer Pract200210 Suppl 1s14s2012027964
   PubMedGoogle Scholar
• RipamontiCISantiniDMaranzanoEBertiMRoila FESMO Guidelines Working GroupManagement of cancer pain: ESMO clinical practice guidelinesAnn Oncol201223Suppl 7vii139vii15422997447
   PubMed Web of Science ®Google Scholar
• BenedettiCBrockCCleelandCNCCN practice guidelines for cancer painOncology (Williston Park)20001413515011195407
   PubMed Web of Science ®Google Scholar